UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miRNA profiling along tumour progression in ovarian carcinoma

Journal of cellular and molecular medicine, 2011-07, Vol.15 (7), p.1593-1602

2011

Volltextzugriff (PDF)

Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum‐sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry‐based study

Acta obstetricia et gynecologica Scandinavica, 2018-08, Vol.97 (8), p.956-965

2018

Volltextzugriff (PDF)

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance

Human pathology, 2013-05, Vol.44 (5), p.777-785

2013

Volltextzugriff (PDF)

Class III β -tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance

Human pathology, 2011-07, Vol.42 (7), p.1019-1026

2011

Volltextzugriff (PDF)

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers

Molecular cancer, 2007-02, Vol.6 (1), p.12-12

2007

Volltextzugriff (PDF)

SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions

Human pathology, 2012-05, Vol.43 (5), p.669-674

2012

Volltextzugriff (PDF)

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients

International journal of oncology, 2013-07, Vol.43 (1), p.280-288

2013

Volltextzugriff (PDF)

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma

Human pathology, 2013-09, Vol.44 (9), p.1859-1866

2013

Volltextzugriff (PDF)

HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival

Gynecologic oncology, 2013-05, Vol.129 (2), p.358-363

2013

Volltextzugriff (PDF)

HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases

Virchows Archiv : an international journal of pathology, 2012-05, Vol.460 (5), p.505-513

2012

Volltextzugriff (PDF)

Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion

Human pathology, 2013-11, Vol.44 (11), p.2449-2460

2013

Volltextzugriff (PDF)

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

The Lancet (British edition), 2001-01, Vol.357 (9251), p.176-182

2001

Volltextzugriff (PDF)

APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival

American journal of clinical pathology, 2014-07, Vol.142 (1), p.51-57

2014

Volltextzugriff (PDF)

BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma

Virchows Archiv : an international journal of pathology, 2014-06, Vol.464 (6), p.701-707

2014

Volltextzugriff (PDF)

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival

Gynecologic oncology, 2012-09, Vol.126 (3), p.460-465

2012

Volltextzugriff (PDF)

Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index

Cancer chemotherapy and pharmacology, 2012-05, Vol.69 (5), p.1307-1314

2012

Volltextzugriff (PDF)

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status

Tumor biology, 2011-06, Vol.32 (3), p.589-596

2011

Volltextzugriff (PDF)

Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer

Gynecologic oncology, 2006-09, Vol.102 (3), p.447-452

2006

Volltextzugriff (PDF)

Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer

Gynecologic oncology, 2004-07, Vol.94 (1), p.80-85

2004

Volltextzugriff (PDF)

Adjuvant Chemotherapy for Early-Stage Ovarian Cancer: Review of the Literature

Journal of clinical oncology, 2007-07, Vol.25 (20), p.2909-2920

2007

Volltextzugriff (PDF)

Borderline ovarian tumours

Best practice & research. Clinical obstetrics & gynaecology, 2012-06, Vol.26 (3), p.325-336

2012

Volltextzugriff (PDF)

Survival After Secondary Cytoreductive Surgery and Chemotherapy Compared With Chemotherapy Alone for First Recurrence in Patients With Platinum-Sensitive Epithelial Ovarian Cancer and No Residuals After Primary Treatment. A Registry-Based Study

Obstetrical & gynecological survey, 2018-09, Vol.73 (9), p.529-531

2018

Volltextzugriff (PDF)

Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities

Diagnostic cytopathology, 2005-11, Vol.33 (5), p.332-337

2005

Volltextzugriff (PDF)

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

American journal of obstetrics and gynecology, 1993-07, Vol.169 (1), p.40-52

1993

Volltextzugriff (PDF)

Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis

Cancer, 2002-02, Vol.94 (3), p.707-712

2002

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(72)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

miRNA profiling along tumour progression in ovarian carcinoma

Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum‐sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry‐based study

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance

Class III β -tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers

SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma

HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival

HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases

Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival

BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival

Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status

Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer

Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer

Adjuvant Chemotherapy for Early-Stage Ovarian Cancer: Review of the Literature

Borderline ovarian tumours

Survival After Secondary Cytoreductive Surgery and Chemotherapy Compared With Chemotherapy Alone for First Recurrence in Patients With Platinum-Sensitive Epithelial Ovarian Cancer and No Residuals After Primary Treatment. A Registry-Based Study

Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: Importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis

Suchergebnisse filtern